MyAverix Finance MyAverix Finance

US

NKGen Biotech, Inc. Warrants (NKGNW)

NKGen Biotech, Inc. Warrants (NKGNW) is listed on US. As of 2026-03-30, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-30

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for NKGNW

P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

NKGen Biotech, Inc. Warrants (NKGNW) — FAQ

What is NKGNW's P/E ratio?

The price-to-earnings (P/E) ratio for NKGen Biotech, Inc. Warrants (NKGNW) is 18.00 (data as of 2026-03-30).

Does NKGen Biotech, Inc. Warrants pay a dividend?

Dividend yield is not available in the current snapshot for NKGen Biotech, Inc. Warrants (NKGNW). Check the MyAverix Finance app for the latest dividend data.

What exchange is NKGNW listed on?

NKGNW is listed on US.

What is NKGen Biotech, Inc. Warrants's net margin?

NKGen Biotech, Inc. Warrants (NKGNW) reports a net margin of 0.0% (data as of 2026-03-30).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play